Cannabigerol, or CBG, is a non-intoxicating cannabinoid, meaning it doesn’t produce the “highs” that are synonymous with THC. Because it is present in low levels (usually less than 1%) in most cannabis strains, CBG is considered a minor cannabinoid.
Background Info on Cannabigerol (CBG)
THC and CBD start out as CBG. It is the chemical parent of THC and CBD!
Cannabis plants produce Cannabigerolic acid (CBGA), the precursor to the 3 main cannabinoids: Tetrahydrocannabinolic acid (THCA), Cannabidiolic acid (CBDA), and Cannabichromenic acid (CBCA).
To obtain higher yields of Cannabigerol, growers are experimenting with genetic manipulation and cross-breeding of plants.
Medical Benefits of CBG
European research shows evidence that CBG is an effective antibacterial agent, particularly against (MRSA) microbial strains resistant to several classes of drugs. (1)
CBG is showing great promise to fight cancer. (2)
CBG was found to be effective in decreasing the inflammation characteristic of inflammatory bowel disease. (3)